Abstract:Appropriate care for bacteremic patients is dictated by the amount of time needed for an accurate diagnosis. However, the concentration of microbes in the blood is extremely low in these patients (1-100 CFU/mL), traditionally requiring growth (blood culture) or amplification (e.g., PCR) for detection. Current culture-based methods can take a minimum of two days, while faster methods like PCR require a sample free of inhibitors (i.e., blood components). Though commercial kits exist for the removal of blood from these samples, they typically capture only DNA, thereby necessitating the use of blood culture for antimicrobial testing. Here, we report a novel, scaled-up sample preparation protocol carried out in a new microbial concentration device. The process can efficiently lyse 10 mL of bacteremic blood while maintaining the microorganisms' viability, giving a 30-μL final output volume. A suite of six microorganisms (Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Pseudomonas aeruginosa, and Candida albicans) at a range of clinically relevant concentrations was tested. All of the microorganisms had recoveries greater than 55% at the highest tested concentration of 100 CFU/mL, with three of them having over 70% recovery. At the lowest tested concentration of 3 CFU/mL, two microorganisms had recoveries of ca. 40-50% while the other four gave recoveries greater than 70%. Using a Taqman assay for methicillin-sensitive S. aureus (MSSA)to prove the feasibility of downstream analysis, we show that our microbial pellets are clean enough for PCR amplification. PCR testing of 56 spiked-positive and negative samples gave a specificity of 0.97 and a sensitivity of 0.96, showing that our sample preparation protocol holds great promise for the rapid diagnosis of bacteremia directly from a primary sample.

Rapid Bacterial Detection and Gram-Identification Using Bacterially Activated, Macrophage-Membrane-Coated Nanowired-Si Surfaces in a Microfluidic Device

Rapid detection of single bacteria in unprocessed blood using Integrated Comprehensive Droplet Digital Detection

Clearance of ESKAPE Pathogens from Blood Using Bacterially Activated Macrophage Membrane‐Coated Silicon Nanowires

Rapid Concentration and Detection of Bacteria in Milk Using a Microfluidic Surface Acoustic Wave Activated Nanosieve

Rapid identification of bacterial isolates using microfluidic adaptive channels and multiplexed fluorescence microscopy

Microfluidic device for concentration and SERS‐based detection of bacteria in drinking water

Rapid Microbial Sample Preparation from Blood Using a Novel Concentration Device

Rapid and sensitive detection of gram-negative bacteria using surface-immobilized polymyxin B

A microfluidic microwell device operated by the automated microfluidic control system for surface-enhanced Raman scattering-based antimicrobial susceptibility testing

Integrated Microfluidic Chip for Rapid Antimicrobial Susceptibility Testing Directly from Positive Blood Cultures

Highly efficient enrichment and identification of pathogens using a herringbone microfluidic chip and by MALDI-TOF mass spectrometry

Novel Micro-Nanofluidic Chip and Device for Fast Identifying Pathogenic Bacteria

Rapid Identification and Monitoring of Multiple Bacterial Infections Using Printed Nanoarrays

Ultra-sensitive Electrochemical Detection of Bacteremia Enabled by Redox-Active Gold Nanoparticles (ragnps) in a Nano-Sieving Microfluidic System (NS-MFS).

Rapid detection of MRSA using microlfuidic real-time PCR

Rapid and fully automated bacterial pathogen detection on a centrifugal-microfluidic LabDisk using highly sensitive nested PCR with integrated sample preparation

Microfluidic Chip Integrating High Throughput Continuous-Flow PCR and DNA Hybridization for Bacteria Analysis.

Automated sepsis detection with vancomycin- and allantoin-polydopamine magnetic nanoparticles

Nanoplasmonic Rapid Antimicrobial‐Resistance Point‐of‐Care Identification Device: RAPIDx

A Rapid Bioassay for Single Bacterial Cell Quantitation Using Bioconjugated Nanoparticles.

A High Speed Detection Platform Based on Surface-Enhanced Raman Scattering for Monitoring Antibiotic-Induced Chemical Changes in Bacteria Cell Wall